Valuation: Getinge AB

Market Cap 68.26B 6.84B 6.07B 5.68B 5.15B 9.73B 659B 9.8B 26.55B 336B 25.68B 25.13B 1,082B P/E 2026 *
21.8x
P/E 2027 * 19.2x
Enterprise Value 76.46B 7.66B 6.8B 6.37B 5.77B 10.9B 739B 10.98B 29.74B 377B 28.77B 28.15B 1,212B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 1.98x
Free-Float
79.13%
Yield 2026 *
2.07%
Yield 2027 * 2.26%
1 day+2.26%
1 week+0.36%
Current month+1.60%
1 month+1.93%
3 months+18.12%
6 months+27.14%
Current year+10.99%
1 week 21.67
Extreme 21.67
22.16
1 month 20.71
Extreme 20.71
22.16
Current year 16.36
Extreme 16.355
22.18
1 year 16.36
Extreme 16.355
22.18
3 years 14.23
Extreme 14.23
22.18
5 years 14.23
Extreme 14.23
42.95
10 years 7.17
Extreme 7.168
42.95
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+2.26%+0.36% - - 6.78B
-1.94%-2.76%-26.60%+1.32% 173B
-1.00%0.00%-11.52%+14.41% 113B
-2.46%-0.20%-24.05%+4.65% 109B
+1.52%+1.45%-46.87%-10.58% 74.44B
+0.46%+2.85%+3.63%+72.08% 60.1B
-0.83%+6.40%+11.24%+66.10% 51.87B
-0.20%-0.92%-6.09%-31.29% 49.21B
-2.21%-3.38%-17.90%+15.57% 41.52B
-4.04%-3.75%+25.66%+0.20% 32.79B
Average -0.84%-0.32%-10.28%+14.72% 78.34B
Weighted average by Cap. -1.18%-0.47%-16.20%+11.98%

Financials

2026 *2027 *
Net sales 35.35B 3.54B 3.15B 2.94B 2.67B 5.04B 342B 5.08B 13.75B 174B 13.3B 13.02B 560B 37.54B 3.76B 3.34B 3.13B 2.83B 5.35B 363B 5.39B 14.6B 185B 14.12B 13.82B 595B
Net income 3.18B 319M 283M 265M 240M 453M 30.73B 457M 1.24B 15.68B 1.2B 1.17B 50.4B 3.59B 360M 319M 299M 271M 512M 34.69B 515M 1.4B 17.7B 1.35B 1.32B 56.9B
Net Debt 8.21B 822M 730M 683M 619M 1.17B 79.28B 1.18B 3.19B 40.44B 3.09B 3.02B 130B 6.02B 604M 536M 501M 454M 858M 58.18B 865M 2.34B 29.68B 2.27B 2.22B 95.42B
Projected Income Statement - Annual - Getinge AB
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change
06/10/26 €22.16 +2.26%
05/10/26 €21.67 -0.78%
02/10/26 €21.84 +0.51%
01/10/26 €21.73 -0.37%
30/09/26 €21.81 -1.22%
Trader
Investor
Global
Quality
ESG MSCI
B
Ratings Surperformance© - Getinge AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
250.60SEK
Average target price
252.20SEK
Spread / Average Target
+0.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Getinge AB